Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Dose CFZ533 in Rheumatoid Arthritis Patients
Clinical trial NCT02089087 · COMPLETED
Trial details
- NCT number
- NCT02089087
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-01-07
- Primary completion
- 2017-02-03
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.